Flight Margin declined to 14.3% in the current quarter, as expected, from 16.0% in the prior year period. "We are pleased to deliver strong fourth quarter results to close out a monumental year for Blade," said Rob Wiesenthal, Blade’s Chief Executive Officer. "Strong organic growth in MediMobility Organ Transport coupled with our acquisitions in Europe and Canada drove record Revenue and Flight Profit in calendar year 2022. As we navigate a dynamic macro environment, we continue to believe that Blade is well positioned to thrive in any economic climate, particularly given the non-discretionary nature of our Medical business, the resilience of our fliers and the supply flexibility afforded by our asset-light model."
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on BLDE:
- Blade Air Mobility Reports Financial Results for the Fourth Quarter and Calendar Year Ended December 31, 2022
- Blade Air Mobility to participate in a conference call with Oppenheimer
- Blade Air Mobility Announces Date for Fourth Quarter and Calendar Year Ending December 31, 2022 Earnings Release Conference Call
- Blade Air Mobility and BETA Technologies complete historic Electric Vertical Aircraft flight in New York
- Blade Air Mobility announces completion of electric aircraft test flight